Histogen Inc. (HSTO) Social Stream



Histogen Inc. (HSTO): $0.36

0.04 (-9.98%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add HSTO to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#122 of 381

in industry

HISTOGEN INC (HSTO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HISTOGEN INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-11 2 $4 $2.4 $3.2 $0.547 485.01%
2022-03-29 1 $4 $1.5 $2.75 $0.547 402.74%
2022-07-15 1 $30 $30 $30 $0.547 5384.46%

Price Target Last Issued March 29, 2022

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

HSTO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 122 days, HSTO's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • HISTOGEN INC's number of analysts covering the stock is higher than 3.06% of all US stocks.
  • HSTO has a greater upside potential (average analyst target price relative to current price) than 476.77% of all US stocks.
  • HSTO has a higher average analyst price target than 223.12% of stocks in the micro market cap category.
  • In terms of how HISTOGEN INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -198.18% of that group.

In the Pharmaceutical Products industry, SNOA, OCUP, and OGEN are the three stocks most similar to HISTOGEN INC regarding the price target and analyst recommendation information presented here.

Is HSTO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!